Stock Analysts

3 Energy MLPs for Solid Gains

Oil & Gas-focused Master Limited Partnerships (MLPs) boast a consistent and robust performance history, and their future looks bright as well. A recently held National Association of Publicly Traded Partnerships conference provided a positive outlook on this asset class. The conference concluded that midstream MLPs are expected to generate two-figure distribution growth in the next three to five years […]

Stock Analysts

LinkedIn Expands Base in China

LinkedIn ’s ( LNKD ) strategic launch of the Chinese language website tasted early success with memberships surpassing 5 million in the country. As reported by Forbes, membership count in China rose approximately 1 million since LinkedIn’s official launch of the new website in simplified Chinese in February this year. China, being the world's most populated country, with a population of over 1.35 billion, remains LinkedIn’s focal point for its international expansionary initiatives. […]

Mergers & Acquisitions

Mattamy Homes purchases Thomas Ranch property for $86.25 million

Mattamy Homes purchases Thomas Ranch property for $86.25 million PR Newswire OAKVILLE, ON, May 29, 2014 Mega-deal positions leading North American builder for long-term success in southwest Florida OAKVILLE, ON , May 29, 2014 /PRNewswire/ – In one of the largest residential land transactions in the United States in the last 10 years, Mattamy Homes has purchased the Thomas Ranch property from Thomas Enterprises. The deal, valued at $86.25 million and encompassing more than 9,600 acres, closed on Wednesday May 28, 2014 . Thomas Ranch is located in southwest Florida , in the Sarasota metropolitan statistical area (MSA), with more than 6,000 acres in the City of North Port and another 3,650 acres in unincorporated Sarasota County […]

Stock Analysts

Greif Down to Sell

On May 29, Zacks Investment Research downgraded Greif, Inc. ( GEF ), a provider of packaging services, to a Zacks Rank #4 (Sell) from Zacks Rank #3 (Hold). Why the Downgrade […]

Stock Analysts

Omnicell Retains Balanced View

On May 29, 2014, we issued an updated research report on Omnicell Inc. ( OMCL ). The company recently reported better-than-expected first quarter results beating the Zacks Consensus Estimate on both lines […]

Stock Analysts

Twitter Surges on Growing User Base

Shares of Twitter ( TWTR ) jumped 10.69% ($3.26) to close at $33.77 on May 28, 2014, following positive comments from CEO Dick Costolo. Recently, Twitter’s CEO expressed his optimism over the company’s growing user base. […]

FDA Approval

BioLight Announces Distribution Agreement for IOPtiMate™ Systems in China

BioLight Announces Distribution Agreement for IOPtiMate™ Systems in China Receives commitment to purchase at least 100 systems in one of the world’s largest glaucoma markets PR Newswire TEL AVIV, Israel, May 29, 2014 TEL AVIV, Israel , May 29, 2014 /PRNewswire/ — BioLight Life Sciences Investments Ltd. (OTC: BLGTY, TASE: BOLT) , a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announced today that its IOPtima subsidiary has signed an exclusive distribution agreement for the sale and marketing of the IOPtiMate [TM] system in China , one of the world’s largest glaucoma markets. As part of the agreement, IOPtima received a commitment that at least 100 systems will be purchased during the initial term of the agreement. […]

Stock Analysts

Sanderson Beats on Q2 Earnings

Sanderson Farms, Inc. ( SAFM ) reported upbeat fiscal second-quarter 2014 (ended Apr 30, 2014) results. Earnings coming in at $2.21 per share exceeded twice the year-ago quarter figure of $1.06. […]

Stock Analysts

Pall Corp. Q3 Earnings Miss, Revs Beat

Pall Corporation ( PLL ) reported third-quarter fiscal 2014 (ended Apr 30, 2014) pro forma earnings of 81 cents a share, 2.4% below the Zacks Consensus Estimate of 83 cents. However, earnings were 9.5% above the prior-year quarter's earnings of 74 cents a share. […]

Stock Analysts

Sanofi-Eli Lilly Collaborate for OTC Cialis

Several pharma companies with consumer healthcare segments have been working on making prescription (Rx) drugs available over the counter (OTC). Rx-to-OTC switches ensure that patients can easily access these drugs without having to go to the physician. Some prescription drugs that were converted to OTC include Nasacort Allergy 24HR (nasal spray – allergic rhinitis), Allegra, Allegra D 12 hr and Allegra 24 hr (antihistamine), Prevacid 24 HR (acid reducer/PPI – proton pump inhibitor) and Zegerid OTC (acid reducer/PPI) among others […]

Stock Analysts

CVS Caremark: Updated Research Report

On May 29, 2014, we issued an updated research report on CVS Caremark Corporation ( CVS ). The company recently reported a mixed first-quarter 2014 with earnings per share lagging the Zacks Consensus Estimate and revenues coming in higher than expected. After several quarters of solid progress, CVS Caremark disappointed with its earnings figure of $1.02 which although 22.9% higher on a year-over-year basis, missed the Zacks Consensus Estimate by 3 cents as well as the company-provided guidance range of $1.03 to $1.06 per share. […]

Stock Analysts

BNY Mellon To Face Tax Liability Charges, Shares Fall

Share price of The Bank of New York Mellon Corporation ( BK ) fell nearly by 1% after it disclosed that it will record a one-time after tax charge of $100 million in second-quarter 2014 on Tuesday. The charge results from an administrative error, due to which a particular fund managed by the company was incorrectly given a residential status. The error in status of the fund led to unwanted tax exemption on BNY Mellon’s front […]

Max Keiser

Keiser Report: Crack Boosted GDP (E607)

[youtube se0bkAFCULY] In this episode of the Keiser Report, Max Keiser and Stacy Herbert discuss driving GDP high on cocaine, banking fraud and new-fangled derivatives products. In the second half, Max interviews Satyajit Das about China’s debt problems and central banks’ printing presses. […]

FDA Approval

Safinamide New Drug Application (NDA) Submitted to the US Food and Drug Administration (FDA)

Safinamide New Drug Application (NDA) Submitted to the US Food and Drug Administration (FDA) PR Newswire MILAN, May 29, 2014 MILAN , May 29, 2014 /PRNewswire/ — Newron Pharmaceuticals S.p.A. (“Newron”), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA). The submission covers the indications “safinamide as add-on therapy to a stable dose of a single dopamine agonist” in early Parkinson’s disease patients and “safinamide as add-on therapy to levodopa alone or in combination with other Parkinson’s disease treatments” in mid-to late stage Parkinson’s disease patients […]

Kitco Video

Gold & Silver Bears In Command, Technical Posture Deteriorating: Wyckoff | Kitco News

[youtube TyUncxIGHKA] Kitco News speaks with Jim Wyckoff, following continued pressure on gold, to see where he thinks the metal is headed. “Near-term technical posture of the gold market has deteriorated significantly,” he says. “The bears are still in firm technical command of both gold and silver.” Wyckoff also says that although tensions in the Ukraine have simmered down, there is still violence there that traders should keep an eye on […]